All relevant data are within the paper.

Introduction {#sec004}
============

*Orientia tsutsugamushi* is an antigenically variable pathogen. This obligate intracellular bacterium causes scrub typhus, a common tropical rickettsial febrile illness endemic across much of the Asia-Pacific region \[[@pntd.0004723.ref001]--[@pntd.0004723.ref005]\]. *O*. *tsutsugamushi* is vertically maintained in mites of the *Trombiculidae* family and transmitted to humans by the bite of the larval stage, called chiggers \[[@pntd.0004723.ref006]\]. Scrub typhus is the leading cause of treatable febrile illness and endemic in many parts across Asia. Despite its easily treatable nature, scrub typhus is difficult to diagnose and no vaccine is currently available. Although antibiotic therapy with either doxycycline or azithromycin can achieve an effective cure, treatment does not affect incidence rates, as humans are dead-end hosts \[[@pntd.0004723.ref007]\]. Further, it was shown that protective immunity to a homologous strain can last several years, but heterologous protection in treated patients and natural disease survivors can last for a few months only. This short-lived heterologous, but intermediate to long-lived homologous immunity results in a high recurrence rate of disease, which is further complicated by the broad antigenic heterogeneity of strains \[[@pntd.0004723.ref006],[@pntd.0004723.ref008],[@pntd.0004723.ref009]\].

Historically, *O*. *tsutsugamushi* (formerly *Rickettsia tsutsugamushi*) was classified into antigenic groups on the basis of their sero-reactivity against prototype strains (i.e. Karp, Kato, and Gilliam). Since the 1940s, the discovery of the antigenic heterogeneity of *O*. *tsutsugamushi* strains has posed a real obstacle for all progress regarding strain classification, diagnostic and vaccine development and epidemiological studies of scrub typhus. Numerous functional cross-reactivity and cross-vaccination studies have contributed towards the characterization of Orientia immunogens and their strain-specific or group-specific serological properties \[[@pntd.0004723.ref010]--[@pntd.0004723.ref012]\]. Unfortunately this work has not led to any translational output towards an improved classification scheme or identification of broadly cross-protective antigens.

Antigenic cartography is a computational tool that is applied to assays of cross-reactivity, and can transform datasets of serological titres into an antigenic map. These maps enable a quantitative visualization of relevant antigenic variation among the pathogens \[[@pntd.0004723.ref013]\]. This methodology has been applied successfully to viral diseases, mainly influenza, and also dengue virus, foot and mouth disease virus, lyssavirus, flavivirus and enterovirus 71, but not to intracellular bacteria \[[@pntd.0004723.ref014]--[@pntd.0004723.ref018]\]. The basis of antigenic cartography relies on the measurement of titres derived from haemagglutinin inhibition, plaque inhibition, immunofluorescence or neutralization assays producing an endpoint titre that quantitates the neutralizing or diagnostic capacity of the antibody and feeds into the antigenic map. Unfortunately, plaque inhibition assays are not useful due to the fastidious nature of *O*. *tsutsugamushi* and the fact that that most strains do not produce a reliable cytopathic effect (CPE)---although some strains can produce CPE, but only after multiple passages in cell culture. Neutralisation assays would be more appropriate, but antibodies that target the highly strain-specific neutralizing epitopes of *O*. *tsutsugamushi* do not sufficiently represent the humoral immune response \[[@pntd.0004723.ref019]--[@pntd.0004723.ref023]\]. Hence we opted to use binding endpoint titres (BETs)---determined by 2-fold serial serum dilutions titrated onto specially produced single-strain IFA slides---as representative titres to feed into the analysis for antigenic mapping.

The 56-kDa type-specific antigen (TSA) located on the outer membrane surface of *O*. *tsutsugamushi* is the major immunogen and responsible for eliciting neutralizing antibodies \[[@pntd.0004723.ref019]--[@pntd.0004723.ref023]\]. Similar to the lyssavirus trimeric glycoprotein or the influenza haemagglutinin, the 56-kDa TSA is a highly variable surface antigen involved in cell binding and entry and target for neutralizing antibodies \[[@pntd.0004723.ref016],[@pntd.0004723.ref022]--[@pntd.0004723.ref024]\].

The gene encoding the 56-kDa TSA has an ORF of approximately 1,600 bp length, and with its four hypervariable regions contributes substantially to the high diversity among Orientia strains \[[@pntd.0004723.ref020],[@pntd.0004723.ref025]\]. This has hampered the progress on diagnostic test development and candidate vaccine selection \[[@pntd.0004723.ref025]--[@pntd.0004723.ref027]\]. The majority of anti-*Orientia* antibodies of acute and convalescent patient serum contain anti-56-kDa TSA antibodies \[[@pntd.0004723.ref020],[@pntd.0004723.ref021]\]. There are no functional studies that have investigated 56-kDa TSA associated immunoglobulin isotypes and possible effector function that affect immune protection, like antibody cytotoxicity.

In an effort to understand more completely the antigenic and genetic relatedness of *O*. *tsutsugamushi* strains and shed light on sero-diagnostic obstacles, we titrated patient sera against a collection of Thai isolates (including isolate---serum pairs from individual infections) from the same endemic region in NE Thailand and performed antigenic cartography. The antigenic map approach allows us to evaluate if the historically defined Orientia serotypes actually match the observed antigenic clusters on the map, if any antigenic subtypes or clusters exist within these serotypes and how quantitatively different these clusters are.

Methods {#sec005}
=======

Patient specimens and isolates {#sec006}
------------------------------

Whole blood samples were collected from scrub typhus patients in Udon Thani (535 km Northeast of Bangkok) and Tak (512 km Northwest of Bangkok) provinces between September 2003 and August 2005. Twenty-one *O*. *tsutsugamushi* isolates were grown *in vitro* using the method described previously ([Table 1](#pntd.0004723.t001){ref-type="table"}) \[[@pntd.0004723.ref028]\]. Seventeen isolates (19/23; 83%) were from Udon Thani patients (termed UT samples) and four (4/23; 17%) isolates were from Tak patients (FPW samples). Admission and convalescent (where possible) serum was also collected from each patient from which there was an *O*. *tsutsugamushi* isolate, and two additional serum samples were analysed (sera n = 23).

10.1371/journal.pntd.0004723.t001

###### Description of Thai *O*. *tsutsugamushi* isolates of human origin used in this study.

![](pntd.0004723.t001){#pntd.0004723.t001g}

  Isolate   Month/Year isolated   District    Province /Prefecture   Gene length (bp)   GenBank Accession No.   Genotype strain
  --------- --------------------- ----------- ---------------------- ------------------ ----------------------- -----------------
  UT76      09/2003               Muang       Udon Thani             1611               EF213078                Karp
  UT125     10/2003               Muang       Udon Thani             1596               EF213096                Gilliam
  UT144     06/2004               Muang       Udon Thani             1596               EF213091                Gilliam
  UT150     06/2004               Muang       Udon Thani             1611               EF213086                Karp
  UT167     06/2004               Phen        Udon Thani             1611               EF213080                Karp
  UT169     06/2004               Muang       Udon Thani             1608               EF213092                Karp
  UT176     07/2004               Ban Phu     Udon Thani             1602               EF213081                Karp
  UT177     07/2004               Muang       Udon Thani             1605               EF213084                Karp
  UT196     07/2004               Muang       Udon Thani             1596               EF213079                Gilliam
  UT213     07/2004               Sang Khom   Udon Thani             1611               EF213088                Karp
  UT219     07/2004               Muang       Udon Thani             1611               EF213100                Karp
  UT221     08/2004               Muang       Udon Thani             1614               EF213097                Karp
  UT302     08/2004               Muang       Udon Thani             1587               EF213095                TA763
  UT316     10/2004               Muang       Udon Thani             1611               EF213082                Karp
  FPW2016   05/2004               Pho Pra     Tak                    1608               EF213085                Gilliam
  FPW1038   10/2004               Mae Ramat   Tak                    1593               EF213087                TA716
  FPW2031   12/2004               Pho Pra     Tak                    1614               EF213098                Karp
  UT329     7/2005                Na Yang     Udon Thani             1596               EF213099                Gilliam
  UT332     7/2005                Muang       Udon Thani             1611               EF213083                Karp
  UT336     7/2005                Wang Sam    Udon Thani             1599               EF213089                Karp
  UT395     7/2005                Muang       Udon Thani             1611               EF213094                Karp
  FPW2049   7/2005                Pho Pra     Tak                    1596               EF213093                Gilliam
  UT418     8/2005                Muang       Udon Thani             1605               EF213090                Karp

[Note]{.ul}: *Original in vitro isolation and 56 kDa genotyping data is presented elsewhere \[[@pntd.0004723.ref036]\].*

Ethics statement {#sec007}
----------------

Ethical approval was obtained from the Faculty of Tropical Medicine, Mahidol University (Tak study), the Thai Ministry of Public Health (Udon Thani study), and the Oxford Tropical Research Ethics Committee (both studies). All patients in this study provided written informed consent prior to sample collection, if minors were participants, a parent or guardian of any child participant provided written informed consent on their behalf.

*O*. *tsutsugamushi* isolates {#sec008}
-----------------------------

*Orientia* were propagated in Vero cell cultures in 25 cm^2^ tissue culture flasks under biocontainment level 3 conditions. The isolates were harvested when 100% cytopathic effect was microscopically evident, and/or serial cell scrapings reached 100% infection as determined by immunofluorescence microscopy. Whole cell lysates of *O*. *tsutsugamushi* cultures were prepared by mechanical scraping of cells from culture flasks, centrifuging the suspension at 750xg for 10 minutes, discarding the supernatant, re-suspending cells in phosphate-buffered saline (PBS), and repeated pipetting to ensure a uniform host cell lysate solution. The lysate (2ul) was spotted onto each well of 40-well Teflon-coated microscope slides, air-dried and fixed in cold acetone for 10 min. The slides were assessed for uniform distribution of the cell lysate antigen by immunofluorescence microscopy. The slide was either used immediately for further investigations or stored at -20°C until required.

Antigenic analysis {#sec009}
------------------

Antigenic cross-binding analysis was carried out based on a method previously described \[[@pntd.0004723.ref029],[@pntd.0004723.ref030]\]. The method used micro-immunofluorescence to determine antigenic relationships between *O*. *tsutsugamushi* isolates by assessing the level of patient serum binding to homologous and heterologous isolates. Patient sera were serially 2-fold diluted from 1:50 to 1:12,800 in PBS containing 2% (w/v) skim milk powder and incubated in a humidified atmosphere for 30 minutes at 37°C followed by 3 washing cycles in PBS. Anti-human IgA+IgG+IgM FITC conjugate (Jackson, USA) diluted in PBS-SMP diluent containing 0.00125% (w/v) Evans Blue counterstain was applied to all wells and incubated in a humidified atmosphere for 30 minutes at 37°C. The cells were examined by fluorescence microscopy at a magnification of 200x and the binding endpoint titre (BET) was determined as the highest dilution displaying fluorescence, and expressed as the reciprocal value (i.e. 800 for 1:800). Hence, each serum was attributed a BET. For comparisons the reciprocal median titres (RMTs) were calculated within the Karp, Gilliam and TA716 groups; the BETs of related strains within a group were divided by the homologous-paired BET with the reference strain for normalization ([Table 2](#pntd.0004723.t002){ref-type="table"}). Using R software, a heatmap was created based on correlations between normalised patient serum RMTs against the different isolates \[[@pntd.0004723.ref031],[@pntd.0004723.ref032]\].

10.1371/journal.pntd.0004723.t002

###### Summary of homologous and heterologous titres, normalized to give a maximum titre of 100.
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  Patient serum (n = 23)                                                                                                                        
  ----------------------------------------------------- ----------------- ---------------- ----------------- ----------------- ---------------- -----------------
                                                        Karp (n = 14)     75 (3.1--100)    50 (0.8--100)     12.5 (0.4--100)   50 (12.5--100)   18.8 (6.3--100)
  Patient Thai *O*. *tsutsugamushi* isolates (n = 21)   Gilliam (n = 6)   100 (100--100)   25 (0--100)       75 (6.3--100)     100 (25--100)    100 (25--100)
                                                        TA716 (n = 1)     100 (NA)         24.9 (0.4--100)   3.1 (0.4--25)     100 (NA)         6.3 (NA)

[*Abbreviations*]{.ul}: *NA*: *not applicable as one isolate assessed*. *RMT; the reciprocal median titres (RMTs) were calculated by dividing the binding endpoint titre (BET) of each serum sample to various isolates*, *by the BET against its homologous paired strain and reported reciprocally*. *The median RMTs were calculated per group*. *The binding endpoint titre (BET) was determined as the highest dilution displaying positive fluorescence*, *and expressed as the reciprocal value (i*.*e*. *1*,*600 for 1*:*1*,*600*, *and if the homologous paired titer was 12*,*800*, *then the RMT was 1*,*600/12*,*800 = 0*.*125 and reported as RMT 12*,*5)*.

The titers from heterologous paired samples showed that on average anti-Karp sera reacted broader against Gilliam and TA716 strains than anti-Gilliam sera reacted against the Karp-like strains. This data does not illustrate cross-protection, but rather that anti-Karp sera reacted broadly within Karp and showed more cross-reactivity to Gilliam, TA716 and TA763 clusters, while sera raised against Gilliam, remained very Gilliam-specific.

Genotyping {#sec010}
----------

The complete ORF of 56-kDa TSA gene was amplified by conventional PCR using previously described assays complemented with primers for optimal coverage \[[@pntd.0004723.ref033]--[@pntd.0004723.ref035]\]. Nucleotide sequencing was performed by Macrogen, Korea (the MegaBACE Model 1000 automated sequencer (Amersham Bioscience, UK).

Phylogenetic analysis {#sec011}
---------------------

Multiple gene sequence alignment was performed using Clustal X \[[@pntd.0004723.ref036]\]. The aligned sequences of the 56-kDa TSA protein for the strains and sera were used to construct an amino acid phylogenetic tree using PhyML \[[@pntd.0004723.ref037]\]. The LG model of substitution was used with 10 random starts and 1000 bootstrap replicates, using the both Nearest Neighbour Joining and Subtree Pruning and Regrafting. The gamma distribution parameter from estimated from the data and the equilibrium frequencies were taken from the frequencies defined by the substitution model. Both the branch lengths and substitution model parameters were optimised. The best tree and bootstrap values was plotted using R \[[@pntd.0004723.ref031],[@pntd.0004723.ref038]\].

Antigenic cartography {#sec012}
---------------------

Antigenic cartography is a tool that transforms a table of antigenic data (i.e. cross-reactivity titres between strains and sera) into a map of the antigenic relationships between these strains and sera, using the mathematical technique of multi-dimensional scaling. This method was designed for the influenza virus, and typically uses sera from a primary exposure, to exclude confounding pre-existing antibody \[[@pntd.0004723.ref013]\].

The table of titres can be considered a table of antigenic relatedness; a high titre of a particular serum against a particular isolate indicates similarity, while a low titre indicates difference. The tabularized data can mathematically be transformed into a map, such that a serum and antigen pair with a high titre has a small distance between them, and the map distances correlate inversely with the titres in the table. An initial map is generated and then the points (antigens and sera) are moved around in iterations so that the map distances match the table distances better. This is repeated with different random starting points. Thus an antigenic map represents the coordinates for all the antigens and sera used, with the distance between sera and isolates reflecting similarity. More specifically, the titre of serum j against antigen i, termed T~ij~, is transformed into antigenic distances, D~ij~, using the equation: $$\text{D}_{\text{ij}} = \text{b}_{\text{ij}}\text{-}\text{log}_{2}(\text{T}_{\text{ij}})$$

Where b~ij~ is log base 2 of the maximum titre against serum j. A map is generated which minimizes the error function: $$\Sigma_{\text{ij}}(\text{D}_{\text{ij}}\text{-}\text{d}_{\text{ij}})$$

Where d~ij~ is the Euclidean distance between antigen i and serum j in the map. In the case where d~ij~ thresholded titre, for example a titre of \<10, the error function is altered so that this titre only contributes to the error function when d~ij~ \< D~ij~-1 \[[@pntd.0004723.ref013]\].

Maps were created with 1, 2, 3, 4 and 5 dimensions. The maps were optimised by removing a certain proportion (10%, 20%, 30%, 40% or 50%) of the data, and the ability of the map to predict the excluded titres was evaluated. These analyses were performed using lispMDS software \[[@pntd.0004723.ref039]\]. A similar process can be performed on sequence data, treating the number of amino acid substitutions as the distance between the two antigens.

Results {#sec013}
=======

Genetic variation {#sec014}
-----------------

Genetic analysis of the 56-kDa TSA ORF demonstrated that the 21 Thai *O*. *tsutsugamushi* isolates and two additional sera in this study were related to Karp, Gilliam and TA716 prototype strain genotypes ([Fig 1](#pntd.0004723.g001){ref-type="fig"} and [Table 2](#pntd.0004723.t002){ref-type="table"}). Phylogenetic details have been discussed previously \[[@pntd.0004723.ref035]\].

![Antigenic relatedness of Thai *O*. *tsutsugamushi* isolates against homologous and heterologous sera.\
Heatmap of the correlation between the patient serum responses of the different isolates. The dendrogram was produced using *distance = 1-correlation*. Genetic assignment of the *O*. *tsutsugamushi* isolates based on 56 kDa gene analysis is represented by the colored bars on top and left of the heat map (Gilliam in red, Karp in blue and TA716 in yellow).](pntd.0004723.g001){#pntd.0004723.g001}

Antigenic variation {#sec015}
-------------------

Homologous and heterologous reactivity of antigen and patient serum pairs demonstrated distinct groupings that corresponded to the Karp and Gilliam clusters based on 56-kDa TSA genetic analysis; the sera raised against Gilliam-like strains discriminated between Karp-like and Gilliam-like strains ([Table 2](#pntd.0004723.t002){ref-type="table"}). Antibody titers in homologous serum-isolate pairs were not always highest in Karp/ Karp-like samples, whereas for Gilliam and TA716 strains this was the case ([Table 2](#pntd.0004723.t002){ref-type="table"}). Sera raised against Karp strains reacted more weakly with corresponding homologous strains (Karp RMT 75) than the sera homologous strain pairs for Gilliam and TA716 strains (homologous RMTs each 100). However, the heterologous paired titres in the Karp group showed a greater reactivity against all other strains (Karp RMT 50; Gilliam RMT 12.5; TA716 RMT 50; TA763 RMT 18.8), than Gilliam sample pairs did (Karp RMT 25; Gilliam RMT 75; TA716 RMT 25; TA763 RMT 100). Sera from infections with Karp-like genotype demonstrated greater heterologous antigen reactivity, with broader cross-reactivity into Gilliam-like isolates ([Fig 2](#pntd.0004723.g002){ref-type="fig"}, panel A).

![An overview of antigenic mapping and genetic variation of *O*. *tsutsugamushi* Thai isolates.\
Panel A: Antigenic map of indirect immunofluorescence titres in [Table 3](#pntd.0004723.t003){ref-type="table"}. Calculating the antigenic distance between points gives a measure of antigenic similarity allowing quantitative visualization of serological data for *O*. *tsutsugamushi*. Points close to each other are antigenically similar. Each circle represents an *O*. *tsutsugamushi* isolate, and each square represents a serum. The grid background of panel A indicates antigenic distance; the spacing between grid lines is 1 antigenic unit, corresponding to a twofold dilution of patient sera in the indirect immunofluorescence assay. The points are colored according to their genetic group, as determined in panel C. Panel B: A genetic map of the strains and sera in panel A, with additional prototype strains. The grid spacing is every 10 units of genetic distance (amino acid mutations). The genetic map was made using the same method as the antigenic map, but using the genetic distance (number of mutations) as opposed to a measure of antigenic distance. Panel C: A phylogenetic tree of the 56kDa protein amino acid sequences of *O*. *tsutsugamushi* strains and human sera used in this study, with bootstrap values on the nodes.](pntd.0004723.g002){#pntd.0004723.g002}

Antigenic cross-reactivity results {#sec016}
----------------------------------

The dendrogram generated from correlations between normalised titres demonstrated two main antigenic groups which associated with the Karp and Gilliam genotypic strains, with the TA716-related isolate bifurcating within the Karp-like grouping ([Fig 1](#pntd.0004723.g001){ref-type="fig"}), the heatmap, showing mainly positive correlation between normalised IFA-based BETs. However, the serum responses to the Gilliam-like isolates show negative correlations to a set of serum responses to the Karp-like isolates. Generally higher correlations, expressed as darker shades of pink ([Fig 1](#pntd.0004723.g001){ref-type="fig"}), were found within genotypes rather than between genotypes, but antigenic similarities were not as marked as genetic similarities. The detailed phylogenetic tree is shown in [Fig 2](#pntd.0004723.g002){ref-type="fig"}, panel C.

Antigenic cartography for *O*. *tsutsugamushi* {#sec017}
----------------------------------------------

The antigenic maps for *O*. *tsutsugamushi* shown in [Fig 2](#pntd.0004723.g002){ref-type="fig"} plots the antigenic distance along the x- and y-axis using antigenic units. One antigenic unit corresponds to a two-fold difference in the patient serum titre. The predictive ability of the map was optimised when in three dimensions, however there was only a small improvement in two dimensions. When 20% of the titres were excluded, the average prediction error was 1.28 for 1D, 1.14 for 2D, 1.10 for 3D, 1.12 for 4D, 1.13 for 5D.

Although the number of strains in this dataset is not large, there were two main clusters of antigens: a Karp-like group and a Gilliam-like group. There was a single TA716-like strain, which was separate from the Karp-like and Gilliam-like groups. The positions of the sera in the antigenic map were not well clustered with the antigens ([Fig 2](#pntd.0004723.g002){ref-type="fig"}, panel A). The sera against the TA716-like strain were indistinguishable from sera against Gilliam-like or Karp-like strains respectively. The sera from individuals infected with Gilliam-like strains generally had higher titres to the Gilliam-like strains than to the Karp-like strains, whereas the sera against Karp-like strains tended to be more broadly reactive ([Fig 1](#pntd.0004723.g001){ref-type="fig"}).

One might expect paired homologous isolates and sera to be close to each other on the map. This is not seen in antigenic cartography of influenza, nor here. The average \[±standard deviation\] distance between a strain and its homologous serum was 1.8 \[±1.1\] antigenic units. The Gilliam-like strains tended to be closer to their homologous sera, and there was only a single representative of the TA716-like strains, limiting conclusions about their antigenic properties.

Relationship between genotype and antigenic phenotype {#sec018}
-----------------------------------------------------

Visual comparison of the phylogenetic tree, based on the amino acid sequences ([Fig 2](#pntd.0004723.g002){ref-type="fig"}, panel C), demonstrate the clear distinction between Gilliam and Karp strains. The Gilliam-like strains, UT144, UT196, UT125 are identical, and are genetically close to FPW2016, FPW2049 and UT329. The Karp-like strains (see [Table 1](#pntd.0004723.t001){ref-type="table"}) are genetically close to each other. Since the Karp-like strains are similar genetically, it is expected that they would cluster together in the antigenic map when compared with the Gilliam-like strains that form a separate cluster.

The genetic map ([Fig 2](#pntd.0004723.g002){ref-type="fig"}, panel B), recapitulates the results from the phylogenetic tree ([Fig 2](#pntd.0004723.g002){ref-type="fig"}, panel C); the *O*. *tsutsugamushi* patient isolates can be grouped into three different types. There were not sufficient numbers of strains to reliably determine genetic correlates of antigenicity.

Discussion {#sec019}
==========

This study showed that there were three groups of antigenic reactivity corresponding to the genetic grouping of the Thai *O*. *tsutsugamushi* isolates in this study around three prototype strain genotypes; Karp, Gilliam and TA716 ([Fig 2](#pntd.0004723.g002){ref-type="fig"}, panels A and B). As not all genetic differences contribute to antigenicity, the clustering in the antigenic maps is less distinct than observed in the genetic map.

The variable pattern of reactivity of sera from different individuals most likely has multiple causes, including differences in time since infection, variation between people in their response to infection, previous infections with homologous and/or heterologous Orientia strains and the antigenic phenotype of the infecting strain. This study investigated sera from acutely ill patients in an endemic area, but did not stratify the data by days of fever or determine possible strain-specific pre-exposure. In individuals infected with Karp-like strains, the serum titres, as measured by IFA, were often high to both Karp-like and Gilliam-like strains. In comparison, those infected with Gilliam-like strains mounted a response more focused on the Gilliam-like strains. This data does not illustrate cross-protection, but rather that anti-Karp sera reacted broadly within Karp and showed more cross-reactivity to Gilliam and TA716 clusters, while sera raised against Gilliam, remained very Gilliam-specific. This effect had been seen before where rabbit sera raised against some prototype strains was multi-specific \[[@pntd.0004723.ref040]\]. Currently the human correlates of protection for scrub typhus are unknown, although phenotypic correlates have been described in a scrub typhus Rhesus macaque model \[[@pntd.0004723.ref041]\]. The exact role of antibodies in protection against scrub typhus has not been fully determined yet, but neutralizing antibodies have been described in association with the 56kDa outer membrane protein, and that the majority of antibodies in the humoral response react against the 56kDa protein \[[@pntd.0004723.ref023],[@pntd.0004723.ref025],[@pntd.0004723.ref026],[@pntd.0004723.ref042]\]. Although antigen-specific functional assays were not part of this study, our data suggests that a vaccine candidate eliciting a Karp-like strain antibody response or derivative would offer broader protection than a Gilliam-like response. However, for controlling this obligate intracellular pathogen, a multivalent, chimeric or T-cell based combination approach may be more appropriate \[[@pntd.0004723.ref009],[@pntd.0004723.ref027]\]. Similarly, these techniques can be used to optimize strain choice in serological testing by determining the minimum set of antigens required to detect the majority of serological responses. The complexity of the serum response is part of the justification for using strain-specific monoclonal antibodies to antigenically characterise *O*. *tsutsugamushi*. However, this approach can mislead if the monoclonal antibodies do not focus on the same epitopes as whole human sera; it may be that whole sera are able to resolve more subtle differences within a serotype. Additionally, it may be valuable to further explore the complexity of the serological response, especially in humans.

A close relationship between the paired strain and homologous serum would be expected in the antigenic map given the strain-specific nature of the 56-kDa TSA and the specificity of the elicited immune responses. However, we found high average distances (expressed as antigenic units) between strains and their homologous sera. Often, the homologous antigen was not the maximum titre for a serum, which would tend to place that antigen away from its homologous serum ([Table 3](#pntd.0004723.t003){ref-type="table"}), a phenomenon which has been previously observed with influenza and dengue viruses \[[@pntd.0004723.ref013],[@pntd.0004723.ref018]\]. The tension between the antigenic differences observed with the sera raised against the different strains contributed to the high distance between homologous strains and sera on the antigenic map. In a related manner, outlying sera (such as the one in the bottom left hand corner of [Fig 2](#pntd.0004723.g002){ref-type="fig"}, panel A) have low titres to the antigens placed centrally and higher titres to the antigens towards the periphery of the map. Thus, the optimum placement of such a serum is out to one side of the map, often away from the homologous antigen. As an exact quantitation of antigen used on the IFA slides is challenging, a complete standardization was not achievable in this study, which may contribute to these patterns.

10.1371/journal.pntd.0004723.t003

###### Overview of all serological titres in this study.
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  *Sera*                                                                                                                                                                                                                                                                                                    
  -------- --------------- ----------- ----------- ----------- ------------- ------------ ------------- ------------- ------------- ----------- ------------- ------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ------- -------
           ***UT76***      **25600**   100         100         100           205600       1600          400           6400          6400        ***25600***   ***25600***   12800       800         12800       100         25600       25600       25600       12800       12800       12800       25600   12800
           **UT125**       12800       **25600**   25600       6400          102400       3200          800           6400          25600       ***25600***   ***25600***   12800       12800       12800       200         6400        6400        800         1600        25600       6400        25600   25600
           **UT144**       6400        25600       **25600**   1600          51200        1600          800           6400          25600       12800         12800         3200        6400        6400        100         6400        6400        800         3200        25600       12800       25600   12800
           ***UT150***     6400        3200        6400        **400**       205600       3200          800           12800         400         3200          3200          1600        200         3200        100         1600        25600       800         1600        3200        800         1600    3200
           ***UT167***     12800       3200        3200        6400          **205600**   1600          1600          ***25600***   6400        ***25600***   ***25600***   6400        3200        25600       200         3200        25600       3200        25600       25600       12800       25600   25600
           ***UT169***     25600       1600        1600        1600          205600       **6400**      1600          6400          1600        6400          12800         3200        400         6400        100         1600        25600       3200        25600       25600       12800       12800   25600
           ***UT176***     12800       3200        3200        100           205600       1600          **400**       6400          400         800           3200          1600        400         12800       50          800         3200        800         1600        6400        3200        3200    3200
           ***UT177***     12800       3200        1600        1600          205600       3200          800           **12800**     800         6400          3200          1600        800         12800       400         3200        25600       1600        12800       25600       25600       12800   12800
           **UT196**       25600       25600       6400        800           102400       1600          1600          800           **25600**   6400          ***25600***   6400        12800       6400        50          6400        3200        400         800         25600       6400        25600   6400
           ***UT213***     12800       12800       6400        3200          205600       3200          400           12800         1600        **12800**     3200          6400        800         3200        100         800         12800       1600        6400        12800       6400        1600    3200
           ***UT219***     25600       6400        6400        3200          51200        ***25600***   3200          ***25600***   12800       12800         **12800**     12800       1600        12800       ***800***   1600        12800       3200        25600       25600       12800       6400    12800
           ***UT221***     25600       6400        3200        3200          102400       6400          1600          6400          1600        12800         3200          **25600**   800         12800       400         25600       25600       25600       25600       25600       12800       3200    12800
           **FPW2016**     25600       25600       25600       6400          205600       3200          3200          6400          25600       ***25600***   ***25600***   12800       **25600**   12800       ***800***   25600       25600       6400        6400        12800       6400        25600   25600
           *FPW1038*       25600       6400        1600        1600          51200        6400          3200          12800         800         6400          3200          1600        800         **25600**   200         100         200         400         100         800         800         1600    6400
           ***FPW2031***   6400        3200        6400        400           102400       3200          400           6400          800         12800         6400          6400        800         12800       **200**     800         6400        3200        3200        12800       3200        6400    12800
           **UT329**       25600       25600       25600       6400          102400       3200          1600          6400          25600       6400          12800         1600        12800       3200        50          **25600**   12800       800         1600        25600       6400        25600   6400
           ***UT332***     25600       25600       25600       ***12800***   205600       ***25600***   ***12800***   ***25600***   800         ***25600***   12800         3200        800         25600       200         3200        **25600**   1600        12800       25600       12800       6400    25600
           ***UT336***     6400        1600        1600        200           102400       ***25600***   800           12800         800         ***25600***   6400          6400        800         12800       100         6400        25600       **25600**   12800       25600       12800       3200    25600
           ***UT395***     12800       6400        6400        400           205600       ***25600***   6400          ***25600***   12800       12800         12800         12800       200         3200        400         12800       25600       12800       **25600**   25600       12800       1600    3200
           ***UT418***     25600       3200        6400        800           205600       3200          800           12800         3200        6400          3200          6400        200         6400        50          1600        25600       3200        12800       **25600**   6400        3200    6400
           **FPW2049**     6400        6400        6400        800           102400       3200          800           1600          12800       6400          6400          3200        1600        3200        0           6400        12800       1600        800         6400        **25600**   6400    1600
           Maximum         25600       25600       25600       12800         205600       25600         12800         25600         25600       25600         25600         25600       25600       25600       800         25600       25600       25600       25600       25600       25600               

The strains and sera are formatted for comparisons to [Fig 2](#pntd.0004723.g002){ref-type="fig"}; in the header rows the Karp strains are formatted in ***bold italics***, Gilliam strains in **bold normal**, TA716 strains in *regular italics*, and TA763 strains formatted in regular normal font.

Homologous titres in the diagonal are formatted in **bold**, and where the homologous titre is not the maximum, the greater than homologous titres are highlighted in ***bold italics***.

Antigenic cartography has typically been applied to antigenic datasets generated from laboratory animal sera with single-strain first infections \[[@pntd.0004723.ref013]\]. Human serology is more complex as humans may have had prior or chronic infections and the time since contracting the disease is uncertain, and ideally first infection sera should be used to generate an antigenic map that is used as a guide to interpret the human serology \[[@pntd.0004723.ref043]\]. An important caveat when interpreting these maps is that the true antigenic distances among *Orientia* isolates are not necessarily reflected, but rather how these particular patient sera relate to the antigens. As such, the antigenic relationships shown in this study may be influenced by the factors described above. Nevertheless, a map was constructed that had reasonable predictive power in two dimensions.

Previous work on other pathogens has generated maps in two or three dimensions; human influenza A/H3N2 and dengue are best described by an antigenic map with two dimensions \[[@pntd.0004723.ref013],[@pntd.0004723.ref018]\]. For one dataset, plotting the map in more than one dimension over fitted the data, resulting in a map that did not perform as well at predicting missing titres despite increasing the number of parameters. However, a dataset with more isolates and sera was best fit in three dimensions suggesting that these additional titrations revealed more about the antigenic relationships. Furthermore, the map may change with the addition of more strains or sera of different antigenic types and from different times. Use of sera from a primary exposure may also affect dimensionality of the antigenic map. However, by analysing previously published data relating to influenza, we found that the most appropriate map generated from human sera was two-dimensional, in keeping with the two-dimensional map made using primary infection sera from ferrets and the same influenza viruses \[[@pntd.0004723.ref043]\].

The apparent strain heterogeneity reflected by a 56-kDa TSA gene-based phylogenetic tree, was simplified upon dissection of the antigenicity of isolates and sera. Scrub typhus patient serum antibody responses were characterised by strong homologous, but weak heterologous antibody titres, with little evidence for cross-reactivity for Gilliam-like sera, but a broader response from some Karp-like sera. Antigenic cartography worked well with scrub typhus immunofluorescence titres. However, a large dataset comprising a broad selection of isolates, and inclusion of strain-specific reference sera raised in naïve animals, will enable further and more complete dissection of the antigenic relationships between Orientia strains and patient sera. This effort will require a network-based multinational collaborative approach.
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